-
CF Infection Candidate AB569 Kills Resistant Bacteria, Study Finds
AB569, Arch Biopartners’ candidate for bacterial infections in CF and other respiratory diseases, killed bacteria in cell assays and in mice, a study found. Read more about it here.
What do you think about this study and its findings?
Log in to reply.